Shanghai, China

Jianbiao Peng

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2025

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Jianbiao Peng: Innovator in Pharmaceutical Chemistry

Introduction

Jianbiao Peng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. With a total of 9 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is a method for preparing a protein degradation agent compound. This method specifically involves a compound represented by formula (I) and its pharmacologically acceptable salt. The application of this compound is aimed at the degradation of the androgen receptor (AR). Another notable patent involves a phthalazinone compound, detailing both its preparation method and medical use. This compound, also represented by formula (I), is intended for use in degrading the androgen receptor (AR).

Career Highlights

Jianbiao Peng has worked with notable companies in the pharmaceutical industry, including Shanghai Jemincare Pharmaceuticals Co., Ltd. and Jiangxi Jemincare Group Co., Ltd. His experience in these organizations has allowed him to advance his research and development efforts significantly.

Collaborations

Throughout his career, Jianbiao has collaborated with esteemed colleagues such as Haibing Guo and Hongfu Lu. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Jianbiao Peng is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the field. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…